SAFFRON HEALTH PARTNERSHIP — All Prescriptions & Medications — Page 3
Practice Code: E81057 | BIGGLESWADE, SG18 8DJ
Showing results 101-150 of 718
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Memantine hydrochloride | 912 | 26.8K | £4.9K | +176.1% ▲ |
| Mebeverine hydrochloride | 878 | 76.4K | £3.1K | +182.8% ▲ |
| 857 | 8,706 | £2.5K | +243.5% ▲ | |
| Solifenacin | 855 | 26.6K | £1.3K | +79.2% ▲ |
| Other emollient preparations | 834 | 447.6K | £5.7K | +38.9% ▲ |
| 833 | 103.3K | £3.7K | +535.8% ▲ | |
| Linagliptin | 816 | 22.8K | £25.7K | +99.2% ▲ |
| Hydrocortisone | 811 | 21.1K | £3.8K | +80.9% ▲ |
| Hydroxychloroquine sulfate | 799 | 32.3K | £1.7K | +312.6% ▲ |
| 797 | 805 | £35.5K | +156.6% ▲ | |
| Estradiol with progestogen | 796 | 29.9K | £24.3K | +133.6% ▲ |
| Promethazine hydrochloride | 792 | 48.9K | £5.1K | +121.6% ▲ |
| Olanzapine | 785 | 27.5K | £6.9K | +111.9% ▲ |
| Carbamazepine | 758 | 53.6K | £3.9K | +155.4% ▲ |
| Betahistine hydrochloride | 755 | 67.2K | £2.7K | +216.2% ▲ |
| Zolpidem tartrate | 754 | 16.0K | £707 | +736.9% ▲ |
| Pantoprazole | 738 | 23.8K | £1.1K | +168.5% ▲ |
| Digoxin | 734 | 21.3K | £1.6K | +93.9% ▲ |
| Glyceryl trinitrate | 715 | 815 | £1.8K | +202.3% ▲ |
| Senna | 706 | 40.2K | £919 | +17.3% ▲ |
| Rivaroxaban | 685 | 21.5K | £13.6K | +12.0% ▲ |
| Isophane insulin | 683 | 3,519 | £15.2K | +546.9% ▲ |
| 680 | 8,675 | £1.9K | +225.4% ▲ | |
| Loperamide hydrochloride | 679 | 62.7K | £1.6K | +191.5% ▲ |
| Sodium valproate | 663 | 95.8K | £9.0K | +108.4% ▲ |
| Trimethoprim | 663 | 25.4K | £1.3K | +224.5% ▲ |
| Phenoxymethylpenicillin (Penicillin V) | 655 | 48.0K | £1.9K | +113.7% ▲ |
| Lactulose | 646 | 372.8K | £3.4K | +96.2% ▲ |
| Buprenorphine | 646 | 2,958 | £10.3K | +76.3% ▲ |
| Hydroxocobalamin | 641 | 774 | £1.6K | +33.2% ▲ |
| Eplerenone | 640 | 17.8K | £2.2K | +141.3% ▲ |
| Perindopril erbumine | 637 | 19.2K | £1.6K | +20.0% ▲ |
| Mirabegron | 615 | 18.5K | £16.9K | +53.1% ▲ |
| Diltiazem hydrochloride | 608 | 27.3K | £5.2K | +98.0% ▲ |
| 601 | 630 | £3.8K | +154.4% ▲ | |
| Sulfasalazine | 589 | 65.4K | £6.3K | +352.5% ▲ |
| 583 | 38.3K | £2.9K | +624.6% ▲ | |
| Tirzepatide | 580 | 586 | £54.5K | +198.6% ▲ |
| Empagliflozin | 570 | 15.7K | £19.4K | -8.9% ▼ |
| Brinzolamide | 567 | 3,910 | £2.9K | +336.4% ▲ |
| Topiramate | 566 | 34.7K | £3.2K | +218.5% ▲ |
| Tadalafil | 556 | 7,582 | £2.2K | +227.0% ▲ |
| Estriol | 555 | 8,345 | £8.0K | +160.8% ▲ |
| Paroxetine hydrochloride | 554 | 18.2K | £1.1K | +196.9% ▲ |
| Sacubitril/valsartan | 548 | 29.0K | £47.2K | +128.8% ▲ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 546 | 14.5K | £1.6K | +257.5% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 545 | 57.4K | £5.0K | +141.2% ▲ |
| Ranolazine | 541 | 32.4K | £5.9K | +218.3% ▲ |
| Donepezil hydrochloride | 541 | 16.6K | £2.7K | +75.3% ▲ |
| Aripiprazole | 534 | 19.9K | £3.1K | +109.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.